Skip to main content

Table 1 Correlation between GFPT1 expression and clinicopathological variables

From: High GFPT1 expression predicts unfavorable outcomes in patients with resectable pancreatic ductal adenocarcinoma

Variables GFPT1 expression P value
Low (n = 67) High (n = 67)
Age, n (%)    
 <  60 years 29 (43.3%) 35 (52.2%) 0.299
 ≥ 60 years 38 (56.7%) 32 (47.8%)
Sex, n (%)    
 Male 32 (47.8%) 40 (59.7%) 0.166
 Female 35 (52.2%) 27 (40.3%)
Tumor location, n (%)    
 Head and neck 39 (58.2%) 32 (47.8%) 0.229
 Body and tail 28 (41.8%) 35 (52.2%)
Tumor grade, n (%)    
 High and intermediate 40 (59.7%) 42 (62.7%) 0.723
 Low 27 (40.3%) 25 (37.3%)
Tumor size, n (%)    
 ≤ 4.0 cm 53 (79.1%) 49 (73.1%) 0.418
 > 4.0 cm 14 (20.9%) 18 (26.9%)  
Nodal metastasis, n (%)    
 Absence 40 (59.7%) 28 (41.8%) 0.038*
 Presence 27 (40.3%) 39 (58.2%)  
Perineural infiltration, n (%)    
 Absence 10 (89.1%) 13 (77.6%) 0.492
 Presence 57 (10.9%) 54 (22.4%)
Vessel invasion, n (%)    
 Absence 51 (76.1%) 57 (85.1%) 0.190
 Presence 16 (23.9%) 10 (14.9%)  
CA199 level, n (%)    
 ≤ 37 U/ml 26 (38.8%) 19 (28.4%) 0.200
 >  37 U/ml 41 (61.2%) 48 (71.6%)  
  1. GFPT1 glutamine-fructose-6-phosphate transaminase 1, CA199 carbohydrate antigen 199
  2. *P value < 0.05